Gw Pharmaceuticals Plc Ads (GWPH) 46.20 $GWPH
NTRR to Showcase New Vapor Pen at Cannabis Cup
Business Wire - Thu Apr 17, 4:00AM CDT
The executive leadership from Neutra Corp. (OTCBB: NTRR) will travel to Denver this week to seek out distribution and build brand awareness for the company's new vapor pen at one of the world's largest cannabis conventions: the Cannabis Cup.
Marijuana Index Fights Through Recent Pressure - Company Looks To Reduce Outstanding Shares To Fund Expansion
PR Newswire - Wed Apr 16, 7:30AM CDT
Cannabis companies remain productive despite industry's recent market reaction: Zoned Properties, Inc. (OTC: ZDPY), GW Pharmaceuticals plc (NASDAQ: GWPH), Medbox, Inc. (OTC: MDBX), Cannabis-Rx Inc. (OTC: CANA) and Vape Holdings, Inc. (OTC: VAPE)
Medical Marijuana Operators and Facility Providers Expand Operations - Company Adds Well Known, Major Marijuana Authority to Board of Directors
PR Newswire - Tue Apr 15, 7:50AM CDT
Market news updates for Cannabis sector that continues to display growth as companies improve operations moving forward: Zoned Properties, Inc. (OTC: ZDPY), GW Pharmaceuticals plc. (NASDAQ: GWPH), Cannabis-Rx Inc. (OTC: CANA), Embarr Downs, Inc. (OTC: EMBR), Hemp, Inc. (OTC: HEMP) and Terra Tech Corp. (OTC: TRTC)
Marijuana Sector Turns Green with High Volume Activity - Company Strengthens Security Platform With Highly Experienced CTO In Cyber Security Industry
PR Newswire - Thu Apr 10, 7:50AM CDT
Marijuana sector trended up on Wednesday as companies aim to strengthen their position in evolving industry: The CannaBusiness Group, Inc. (OTC: CBGI), Hemp, Inc. (OTC: HEMP), MediSwipe, Inc. (OTC: MWIP), GW Pharmaceuticals plc (NASDAQ: GWPH) and Medical Cannabis Payment Solutions (OTC: REFG)
1 Comment
Marijuana: The Most Dangerous Investment You Can Make?
Sean Williams, The Motley Fool - Motley Fool - Sat Apr 05, 10:04AM CDT
To put it mildly, marijuana stocks have been smoking hot this year as the lines surrounding the legality of the drug and public perception have blurred a bit. While still classified as a class 1 illegal substance by the U.S. federal government,...
Down 20%: Plummeting Pot Stock Scandal
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Thu Apr 03, 7:40PM CDT
For investors continuing to search for a dominant player to invest in to get early exposure to the nascent marijuana industry in the U.S., today's crash for Cannavest may serve as a sobering reminder that this is still an extremely difficult area...
NTRR Readies New Asset for Distribution Network
Business Wire - Tue Apr 01, 4:00AM CDT
Neutra Corp. (OTCBB: NTRR) announced today that representatives from its wholly owned subsidiary, Diamond Anvil Designs, will attend the world's top cannabis industry show this month to secure distributions for the company's revolutionary new vapor pens.
From Marijuana to Snake Venom: 9 Drugs Derived from Unlikely Sources
Sean Williams, The Motley Fool - Motley Fool - Sat Mar 29, 10:03AM CDT
Every sector relies on innovation to grow to some extent, but it's possibly the most vital component to success in the biotech sector. Biopharmaceutical companies don't have the luxury of simply sitting on their laurels and living off of the...
CannabisFN Weekly: Stocks Rally Ahead of Canada's MMPR Implementation
ACCESSWIRE - Mon Mar 24, 8:02AM CDT
Whitefish, MT / March 24, 2014 / The Marijuana Index™ moved lower last week due to a fall in GW Pharmaceuticals plc (OTCBB: GWPH), which accounts for 15.81% of the market capitalized weighted index, but these losses were offset by gains in many other components of the index. Investors have also been eyeing the upcoming MMPRs in Canada, which are set to become law on April 1, 2014, as well as ongoing favorable regulations in the United States.
Cannabis Sector Continues Rapid Expansions - Company Locates Headquarters in California & Announces 506 Capital Raise Initiative
PR Newswire - Fri Mar 21, 8:05AM CDT
Legal Marijuana Markets continues upward trend at an astonishing rate as companies make moves to bolster presence in cannabis industry: The CannaBusiness Group, Inc. (OTC: CBGI), Nuvilex, Inc. (OTC: NVLX), GW Pharmaceuticals plc (NASDAQ: GWPH), Anything Technologies Media Inc. (OTC: EXMT) and Hemp, Inc. (OTC: HEMP)
FDA Approvals, Financial Highlights, Restated Treatment Indications, and Updates on Product Pipelines - Analyst Notes on Bristol-Myers Squibb, Galena, Teleflex, GW Pharmaceuticals, and CytRx
PR Newswire - Fri Mar 21, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Bristol-Myers Squibb Company (NYSE: BMY), Galena Biopharma, Inc. (NASDAQ: GALE), Teleflex Incorporated (NYSE: TFX), GW Pharmaceuticals plc (NASDAQ: GWPH), and CytRx Corporation (NASDAQ: CYTR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Jim Cramer: Very Difficult to Crush This Market
at The Street - Thu Mar 20, 1:36PM CDT
Financials and tech, the most vital groups to the broader market, are far too robust.
NTRR: Cannabis Market Growth Poised to Outpace Smartphones
Business Wire - Wed Mar 19, 4:00AM CDT
Cannabis is among the fastest-growing markets in the U.S., poised to outpace the expansion of the global smartphone market--and Neutra Corp. (OTCBB: NTRR) is readying a diverse product line to capitalize on that growth.
Medical Marijuana Industry Hitting New Highs -Company Closes $4.6 Million Dollar Acquisition of 83,000 S/F Industrial Park
PR Newswire - Tue Mar 18, 7:45AM CDT
Cannabis leaders make acquisitions as industry experiences rapid growth: Zoned Properties, Inc. (OTC: ZDPY), Advanced Cannabis Solutions, Inc. (OTC: CANN), Medbox, Inc. (OTC: MDBX), GW Pharmaceuticals plc (NASDAQ: GWPH) and Growlife, Inc. (OTCBB: PHOT)
GW Pharmaceuticals Provides Update on Cannabinoid Pipeline
GlobeNewswire - Mon Mar 17, 2:00AM CDT
CBDV Phase 1 Safety Results and Patent Allowance
3 Prescription Drugs You Didn't Know Come From Marijuana
Max Macaluso, The Motley Fool - Motley Fool - Sun Mar 16, 3:15PM CDT
It's no secret that drug discovery is an arduous process; it often takes pharmaceutical companies more than a decade and over $1 billion to bring a new compound to the market. Because of the complexities in discovering new drug candidates from...
3 Stocks Near 52-Week Highs Worth Selling
Sean Williams, The Motley Fool - Motley Fool - Thu Mar 13, 3:03PM CDT
It appears that not even geopolitical concerns and threats of a global growth slowdown can keep the broad-based S&P 500 from running to fresh all-time highs. For skeptics like me, that's an opportunity to see whether companies have earned their...
New Drug Applications, Earnings Release Schedules, Drug Designations, New Services, and Clinical Trials - Analyst Notes on Actavis, Intercept, GW Pharmaceuticals, Galena, and Conatus
PR Newswire - Thu Mar 13, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Actavis plc (NYSE: ACT), Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), GW Pharmaceuticals plc (NASDAQ: GWPH), Galena Biopharma, Inc. (NASDAQ: GALE), and Conatus Pharmaceuticals Inc. (NASDAQ: CNAT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
GW Pharmaceuticals (GWPH) Jumps: Stock Rises 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:18AM CDT
GW Pharmaceuticals plc (GWPH) was a big mover last session, as the company saw its shares rise by roughly 7% on the day.
Cannabis Market Continues Rapid Growth: Advancer with Recent Acquisitions Moves Forward to Become Full Reporting Company
PR Newswire - Wed Mar 12, 8:05AM CDT
The Medical Marijuana and Cannabis Industries forge ahead with indications of reaching a point of public acceptance as TV & radio ads are getting more air time. The bustling industry shows no signs of slowing down as the following companies continue to forge on with lessening restrictions: The CannaBusiness Group, Inc. (OTC: CBGI), Cannabis Science, Inc. (OTC: CBIS), GW Pharmaceuticals plc (NASDAQ: GWPH), MediSwipe, Inc. (OTC: MWIP) and Easton Pharmaceuticals Inc. (OTC: EAPH)
NTRR to Showcase New Vapor Pen at Cannabis Cup
Business Wire - Thu Apr 17, 4:00AM CDT
The executive leadership from Neutra Corp. (OTCBB: NTRR) will travel to Denver this week to seek out distribution and build brand awareness for the company's new vapor pen at one of the world's largest cannabis conventions: the Cannabis Cup.
Marijuana Index Fights Through Recent Pressure - Company Looks To Reduce Outstanding Shares To Fund Expansion
PR Newswire - Wed Apr 16, 7:30AM CDT
Cannabis companies remain productive despite industry's recent market reaction: Zoned Properties, Inc. (OTC: ZDPY), GW Pharmaceuticals plc (NASDAQ: GWPH), Medbox, Inc. (OTC: MDBX), Cannabis-Rx Inc. (OTC: CANA) and Vape Holdings, Inc. (OTC: VAPE)
Medical Marijuana Operators and Facility Providers Expand Operations - Company Adds Well Known, Major Marijuana Authority to Board of Directors
PR Newswire - Tue Apr 15, 7:50AM CDT
Market news updates for Cannabis sector that continues to display growth as companies improve operations moving forward: Zoned Properties, Inc. (OTC: ZDPY), GW Pharmaceuticals plc. (NASDAQ: GWPH), Cannabis-Rx Inc. (OTC: CANA), Embarr Downs, Inc. (OTC: EMBR), Hemp, Inc. (OTC: HEMP) and Terra Tech Corp. (OTC: TRTC)
Marijuana Sector Turns Green with High Volume Activity - Company Strengthens Security Platform With Highly Experienced CTO In Cyber Security Industry
PR Newswire - Thu Apr 10, 7:50AM CDT
Marijuana sector trended up on Wednesday as companies aim to strengthen their position in evolving industry: The CannaBusiness Group, Inc. (OTC: CBGI), Hemp, Inc. (OTC: HEMP), MediSwipe, Inc. (OTC: MWIP), GW Pharmaceuticals plc (NASDAQ: GWPH) and Medical Cannabis Payment Solutions (OTC: REFG)
1 Comment
Marijuana: The Most Dangerous Investment You Can Make?
Sean Williams, The Motley Fool - Motley Fool - Sat Apr 05, 10:04AM CDT
To put it mildly, marijuana stocks have been smoking hot this year as the lines surrounding the legality of the drug and public perception have blurred a bit. While still classified as a class 1 illegal substance by the U.S. federal government,...
Down 20%: Plummeting Pot Stock Scandal
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Thu Apr 03, 7:40PM CDT
For investors continuing to search for a dominant player to invest in to get early exposure to the nascent marijuana industry in the U.S., today's crash for Cannavest may serve as a sobering reminder that this is still an extremely difficult area...
NTRR Readies New Asset for Distribution Network
Business Wire - Tue Apr 01, 4:00AM CDT
Neutra Corp. (OTCBB: NTRR) announced today that representatives from its wholly owned subsidiary, Diamond Anvil Designs, will attend the world's top cannabis industry show this month to secure distributions for the company's revolutionary new vapor pens.
From Marijuana to Snake Venom: 9 Drugs Derived from Unlikely Sources
Sean Williams, The Motley Fool - Motley Fool - Sat Mar 29, 10:03AM CDT
Every sector relies on innovation to grow to some extent, but it's possibly the most vital component to success in the biotech sector. Biopharmaceutical companies don't have the luxury of simply sitting on their laurels and living off of the...
CannabisFN Weekly: Stocks Rally Ahead of Canada's MMPR Implementation
ACCESSWIRE - Mon Mar 24, 8:02AM CDT
Whitefish, MT / March 24, 2014 / The Marijuana Index™ moved lower last week due to a fall in GW Pharmaceuticals plc (OTCBB: GWPH), which accounts for 15.81% of the market capitalized weighted index, but these losses were offset by gains in many other components of the index. Investors have also been eyeing the upcoming MMPRs in Canada, which are set to become law on April 1, 2014, as well as ongoing favorable regulations in the United States.
Cannabis Sector Continues Rapid Expansions - Company Locates Headquarters in California & Announces 506 Capital Raise Initiative
PR Newswire - Fri Mar 21, 8:05AM CDT
Legal Marijuana Markets continues upward trend at an astonishing rate as companies make moves to bolster presence in cannabis industry: The CannaBusiness Group, Inc. (OTC: CBGI), Nuvilex, Inc. (OTC: NVLX), GW Pharmaceuticals plc (NASDAQ: GWPH), Anything Technologies Media Inc. (OTC: EXMT) and Hemp, Inc. (OTC: HEMP)
FDA Approvals, Financial Highlights, Restated Treatment Indications, and Updates on Product Pipelines - Analyst Notes on Bristol-Myers Squibb, Galena, Teleflex, GW Pharmaceuticals, and CytRx
PR Newswire - Fri Mar 21, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Bristol-Myers Squibb Company (NYSE: BMY), Galena Biopharma, Inc. (NASDAQ: GALE), Teleflex Incorporated (NYSE: TFX), GW Pharmaceuticals plc (NASDAQ: GWPH), and CytRx Corporation (NASDAQ: CYTR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Jim Cramer: Very Difficult to Crush This Market
at The Street - Thu Mar 20, 1:36PM CDT
Financials and tech, the most vital groups to the broader market, are far too robust.
NTRR: Cannabis Market Growth Poised to Outpace Smartphones
Business Wire - Wed Mar 19, 4:00AM CDT
Cannabis is among the fastest-growing markets in the U.S., poised to outpace the expansion of the global smartphone market--and Neutra Corp. (OTCBB: NTRR) is readying a diverse product line to capitalize on that growth.
Medical Marijuana Industry Hitting New Highs -Company Closes $4.6 Million Dollar Acquisition of 83,000 S/F Industrial Park
PR Newswire - Tue Mar 18, 7:45AM CDT
Cannabis leaders make acquisitions as industry experiences rapid growth: Zoned Properties, Inc. (OTC: ZDPY), Advanced Cannabis Solutions, Inc. (OTC: CANN), Medbox, Inc. (OTC: MDBX), GW Pharmaceuticals plc (NASDAQ: GWPH) and Growlife, Inc. (OTCBB: PHOT)
GW Pharmaceuticals Provides Update on Cannabinoid Pipeline
GlobeNewswire - Mon Mar 17, 2:00AM CDT
CBDV Phase 1 Safety Results and Patent Allowance
3 Prescription Drugs You Didn't Know Come From Marijuana
Max Macaluso, The Motley Fool - Motley Fool - Sun Mar 16, 3:15PM CDT
It's no secret that drug discovery is an arduous process; it often takes pharmaceutical companies more than a decade and over $1 billion to bring a new compound to the market. Because of the complexities in discovering new drug candidates from...
3 Stocks Near 52-Week Highs Worth Selling
Sean Williams, The Motley Fool - Motley Fool - Thu Mar 13, 3:03PM CDT
It appears that not even geopolitical concerns and threats of a global growth slowdown can keep the broad-based S&P 500 from running to fresh all-time highs. For skeptics like me, that's an opportunity to see whether companies have earned their...
New Drug Applications, Earnings Release Schedules, Drug Designations, New Services, and Clinical Trials - Analyst Notes on Actavis, Intercept, GW Pharmaceuticals, Galena, and Conatus
PR Newswire - Thu Mar 13, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Actavis plc (NYSE: ACT), Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), GW Pharmaceuticals plc (NASDAQ: GWPH), Galena Biopharma, Inc. (NASDAQ: GALE), and Conatus Pharmaceuticals Inc. (NASDAQ: CNAT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
GW Pharmaceuticals (GWPH) Jumps: Stock Rises 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:18AM CDT
GW Pharmaceuticals plc (GWPH) was a big mover last session, as the company saw its shares rise by roughly 7% on the day.
Cannabis Market Continues Rapid Growth: Advancer with Recent Acquisitions Moves Forward to Become Full Reporting Company
PR Newswire - Wed Mar 12, 8:05AM CDT
The Medical Marijuana and Cannabis Industries forge ahead with indications of reaching a point of public acceptance as TV & radio ads are getting more air time. The bustling industry shows no signs of slowing down as the following companies continue to forge on with lessening restrictions: The CannaBusiness Group, Inc. (OTC: CBGI), Cannabis Science, Inc. (OTC: CBIS), GW Pharmaceuticals plc (NASDAQ: GWPH), MediSwipe, Inc. (OTC: MWIP) and Easton Pharmaceuticals Inc. (OTC: EAPH)
